arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive League10.18705/1607-419X-2009-15-5-539-542arthyper-1429Research ArticleОБЗОРREVIEWПредикторы осложненного течения и неблагоприятного прогноза у больных инфарктом миокардаPredictors of complications and of unfavorable outcomes in myocardial infarctionБобровскаяЕ. Е.BobrovskayaE. E.eebobrovskaya@mail.ruБуроваН. Н.BurovaN. N.noemail@neicon.ruКонВ. Е.KonV. E.noemail@neicon.ruФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»РоссияAlmazov Federal Heart, Blood and Endocrinology Centre, St Petersburg, RussiaRussian Federation200928102009155539542Copyright © Бобровская Е.Е., Бурова Н.Н., Кон В.Е., 20092009Бобровская Е.Е., Бурова Н.Н., Кон В.Е.Bobrovskaya E.E., Burova N.N., Kon V.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/1429

Прогноз осложнений и исходов инфаркта миокарда в течение многих лет является одной из актуальных проблем в кардиологии. При широком выборе лекарственных препаратов и интервенционных методик, используемых влечении инфаркта миокарда, важнейшей задачей является выявление групп пациентов, которые имеют высокий риск развития таких осложнений, как кардиогенный шок, рецидив инфаркта миокарда, острая левожелудочковая недостаточность, фибрилляция желудочков, ранняя постинфарктная стенокардия.

The prognosis of complications and outcomes of myocardial infarction in the course of some years is one of the most important problems in cardiology. With a wide choice of drugs and preventive techniques used for the treatment of myocardial infarction, the most important task is to identify groups of patients at high risk of developing complications such as cardiogenic shock, recurrent myocardial infarction, acute left ventricular failure, ventricular fibrillation, early postinfarction angina pectoris.

инфаркт миокардаострый коронарный синдромсердечно-сосудистые осложненияфакторы неблагоприятного прогнозаmyocardial infarctionacute coronary syndromecardiovascular complicationspoor prognosis determinantsReferencesРаббани Лерой Е. Острые коронарные синдромы не только некроз миоцитов // Междунар. мед. жур. - 2002. - № 1. - С. 25-27.Раббани Лерой Е. Острые коронарные синдромы не только некроз миоцитов // Междунар. мед. жур. - 2002. - № 1. - С. 25-27.Чернецов В.А. Раннее прогнозирование осложнений инфаркта миокарда // Врач. - 2000. - № 2. - С. 25-26.Чернецов В.А. Раннее прогнозирование осложнений инфаркта миокарда // Врач. - 2000. - № 2. - С. 25-26.McGovern P.G., Pankow J.S., Shahar E. et al. Recent trends in acute I coronary heart disease mortality, morbidity, medical care, and risk factors. The Minnesota heart survey investigators // N. Engl. J. Med. - 1996. - Vol. 334. - P. 884-890.McGovern P.G., Pankow J.S., Shahar E. et al. Recent trends in acute I coronary heart disease mortality, morbidity, medical care, and risk factors. The Minnesota heart survey investigators // N. Engl. J. Med. - 1996. - Vol. 334. - P. 884-890.Lee K.L., Woodlief L.H., Topol E.J. et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41.021 patients. GUSTO-1 Investigators // Circulation. - 1995. - Vol. 91. - P. 1659-1668.Lee K.L., Woodlief L.H., Topol E.J. et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41.021 patients. GUSTO-1 Investigators // Circulation. - 1995. - Vol. 91. - P. 1659-1668.Peterson E.D., Shaw L.J., CalilTR.M. Risk stratification alter myocardial infarction // Ann. Intern. Med. - 1997. - Vol. 126. - P. 561-582.Peterson E.D., Shaw L.J., CalilTR.M. Risk stratification alter myocardial infarction // Ann. Intern. Med. - 1997. - Vol. 126. - P. 561-582.Singh N., Mironov D., Armstrong P.W. et al. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries // Circulation. - 1996. - Vol. 93. - P. 1388-1395.Singh N., Mironov D., Armstrong P.W. et al. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries // Circulation. - 1996. - Vol. 93. - P. 1388-1395.Vaccarino V., Horwilz R.I., Meehan T.P. et al. Sex differences in mortality after acute myocardial infarction: evidence for sex-age interaction // Arch. Intern. Med. - 1998. - Vol. 158. - P. 2054-2062.Vaccarino V., Horwilz R.I., Meehan T.P. et al. Sex differences in mortality after acute myocardial infarction: evidence for sex-age interaction // Arch. Intern. Med. - 1998. - Vol. 158. - P. 2054-2062.Zabel K.M., Hathaway W.R., Peterson E.D. et al. Baseline electrocardiogram predicts 30-day mortality among 32,812 patients with acute myocardial infarction treated with thrombolysis [Abstract] // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 342.Zabel K.M., Hathaway W.R., Peterson E.D. et al. Baseline electrocardiogram predicts 30-day mortality among 32,812 patients with acute myocardial infarction treated with thrombolysis [Abstract] // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 342.Пархоменко О.М., Ипкин О.И, Бриль Ж.В. и др. Неинвазивни электрофизиологични маркери виддаленого прогнозу у хворих, що перенесли гострий инфаркт миокарда // Укр. кардиол. журн. - 2001. - № 1. - С. 11-16.Пархоменко О.М., Ипкин О.И, Бриль Ж.В. и др. Неинвазивни электрофизиологични маркери виддаленого прогнозу у хворих, що перенесли гострий инфаркт миокарда // Укр. кардиол. журн. - 2001. - № 1. - С. 11-16.Peterson E.D., Hathaway W.R., Zabel K.M. et al. Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients // J. Am. Coll. Cardiol. - 1996. - Vol. 28. - P. 305-312.Peterson E.D., Hathaway W.R., Zabel K.M. et al. Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients // J. Am. Coll. Cardiol. - 1996. - Vol. 28. - P. 305-312.Ramanathan K., Stewart T. Admission troponin T level can predict 90 minute TIMI flow after trombolysis // Circulation. - 1997. - Vol. 96. - P. 270.Ramanathan K., Stewart T. Admission troponin T level can predict 90 minute TIMI flow after trombolysis // Circulation. - 1997. - Vol. 96. - P. 270.Heeschen C., Hamm C., Goldman B. et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of triofibran // Lancet. - 1999. - Vol. 354. - P. 1757-1762.Heeschen C., Hamm C., Goldman B. et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of triofibran // Lancet. - 1999. - Vol. 354. - P. 1757-1762.Morrison L.J., Verbeek P.R., McDonald A.C. et al. Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis // JAMA. - 2000. - Vol. 283. - P. 2686-2692.Morrison L.J., Verbeek P.R., McDonald A.C. et al. Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis // JAMA. - 2000. - Vol. 283. - P. 2686-2692.Morrow D.A., Rifai N., Antman E.M. et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI HA substudy // J. Am. Coll. Cardiol. - 1998. - Vol. 31. - P. 1460-1465.Morrow D.A., Rifai N., Antman E.M. et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI HA substudy // J. Am. Coll. Cardiol. - 1998. - Vol. 31. - P. 1460-1465.Ridker P.M., Rifai N., Pfeffer M.A. et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein // Circulation. - 1999. - Vol. 100. - P. 230-235.Ridker P.M., Rifai N., Pfeffer M.A. et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein // Circulation. - 1999. - Vol. 100. - P. 230-235.Swahn C., Saftsrom K., Lagcrqvist B. et al. A gender-perspective on the use of lmw-heparin (dalteparin) in the FRISK II medical trial // Eur. Heart J. - 2000. - Vol. 21. - P. 363.Swahn C., Saftsrom K., Lagcrqvist B. et al. A gender-perspective on the use of lmw-heparin (dalteparin) in the FRISK II medical trial // Eur. Heart J. - 2000. - Vol. 21. - P. 363.The GUSTO IV-ACS Investigators. Effect of glycoprotein IIb/IIIa receptors blocker abciximab in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomized trial // Lancet. - 2001. - Vol. 357. - P. 1915-1924.The GUSTO IV-ACS Investigators. Effect of glycoprotein IIb/IIIa receptors blocker abciximab in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomized trial // Lancet. - 2001. - Vol. 357. - P. 1915-1924.Coudrey L. The Troponins // Arch. Int. Med.- 1998. - Vol. 158. - P. 1173-1180.Coudrey L. The Troponins // Arch. Int. Med.- 1998. - Vol. 158. - P. 1173-1180.Ohman E., Armstrong P., Christenson R. et al. Cardiac troponin T levels for risk stratification in acute myocardial infarction // N. Engl. J. Med. - 1996. - Vol. 335. - P. 1333-1341.Ohman E., Armstrong P., Christenson R. et al. Cardiac troponin T levels for risk stratification in acute myocardial infarction // N. Engl. J. Med. - 1996. - Vol. 335. - P. 1333-1341.Heidenreich P.A., Alloggiamenio Т., Melsop K. et al. The prognostic value of troponin in patients wilh non-ST elevalion acute coronary syndromes: a meta-analysis // J. Am. Coll. Cardiol. - 2001. - Vol. 38. - P. 478-485.Heidenreich P.A., Alloggiamenio Т., Melsop K. et al. The prognostic value of troponin in patients wilh non-ST elevalion acute coronary syndromes: a meta-analysis // J. Am. Coll. Cardiol. - 2001. - Vol. 38. - P. 478-485.Rao A.C. Collinson P.O., Сапера-Anson R. et al. Troponin T measurement after myocardial infarction can identify left venticular ejection of less than 40 % // Heart. - 1998. - Vol. 80. - P. 223-225.Rao A.C. Collinson P.O., Сапера-Anson R. et al. Troponin T measurement after myocardial infarction can identify left venticular ejection of less than 40 % // Heart. - 1998. - Vol. 80. - P. 223-225.Миродылов Т'.М. О причинах досуточной летальности при инфаркте миокарда // Л1карсыса справа. - 2002. - № 2. - С. 54-56.Миродылов Т'.М. О причинах досуточной летальности при инфаркте миокарда // Л1карсыса справа. - 2002. - № 2. - С. 54-56.Collinson J., Flalher M., Wright A. et al. Markers of risk in palients with unstable angina and MI wilhoul ST elevalion: UK Prospective Registry of Acute ischacmic Syndromes (PRAIS-UK) // Eur. Heart J. - 1999. - Vol. 20. - P. 281.Collinson J., Flalher M., Wright A. et al. Markers of risk in palients with unstable angina and MI wilhoul ST elevalion: UK Prospective Registry of Acute ischacmic Syndromes (PRAIS-UK) // Eur. Heart J. - 1999. - Vol. 20. - P. 281.Foy S.G., Crozier I.G., Richards A.M. el al. Neurohormonal changes after acute myocardial infarction: relationships wilh haemodynamic indices and effects of ACE inhibition // Eur. Heart J. - 1995. - Vol. 16. - P. 770-778,Foy S.G., Crozier I.G., Richards A.M. el al. Neurohormonal changes after acute myocardial infarction: relationships wilh haemodynamic indices and effects of ACE inhibition // Eur. Heart J. - 1995. - Vol. 16. - P. 770-778,Stanek В., Frey В., Hulsmann M. el al. Prognostic evaluation of neuro-humoral plasma levels before and during bela-blocker therapy in advanced lefl ventricular dysfunction //.1. Am. Coll. Cardiol. - 2001. - Vol. 38. - P. 436-442.Stanek В., Frey В., Hulsmann M. el al. Prognostic evaluation of neuro-humoral plasma levels before and during bela-blocker therapy in advanced lefl ventricular dysfunction //.1. Am. Coll. Cardiol. - 2001. - Vol. 38. - P. 436-442.De Lemos J.K., Morrow D.A., Bertley J.H. et al. The prognostic value of B-type natriuretic pepiide in in palients with acute coronary syndromes // N. Engl. J. Med. - 2001. - Vol. 345. - P. 1014-1021.De Lemos J.K., Morrow D.A., Bertley J.H. et al. The prognostic value of B-type natriuretic pepiide in in palients with acute coronary syndromes // N. Engl. J. Med. - 2001. - Vol. 345. - P. 1014-1021.Fox K.A.A. Management of high risk unstable angina and non-ST segment elevalion myocardial infarction: varialion in practice. Finding from the Global Registry of Acute Coronary Events (GRACE) // Eur. Heart J. - 2000. - Vol. 21. - P. 246.Fox K.A.A. Management of high risk unstable angina and non-ST segment elevalion myocardial infarction: varialion in practice. Finding from the Global Registry of Acute Coronary Events (GRACE) // Eur. Heart J. - 2000. - Vol. 21. - P. 246.Горбачев В.В. Клинико-лабораторные предвестники острого коронарного синдрома и внезапной сердечной смерти // Мед. новости. - Минск, 2001. - № 1 - С. 3-9.Горбачев В.В. Клинико-лабораторные предвестники острого коронарного синдрома и внезапной сердечной смерти // Мед. новости. - Минск, 2001. - № 1 - С. 3-9.Короткова А.А., Титов В.Н., Староверов И.И. Прогностическая роль кардиального тропонина I у больных с острым коронарным синдромом без подъема сегмента ST // Кардиология. - 2002. - № 4. - С. 19-22.Короткова А.А., Титов В.Н., Староверов И.И. Прогностическая роль кардиального тропонина I у больных с острым коронарным синдромом без подъема сегмента ST // Кардиология. - 2002. - № 4. - С. 19-22.Чернецов В.А., Госиодаренко А.Л. Предикторы возникновения рецидивирующих расстройств коронарного кровообращения у больных крупноочаговым инфарктом миокарда // Рос. кардиол. Журн. - 1999. -№ 6. - С. 11-14.Чернецов В.А., Госиодаренко А.Л. Предикторы возникновения рецидивирующих расстройств коронарного кровообращения у больных крупноочаговым инфарктом миокарда // Рос. кардиол. Журн. - 1999. -№ 6. - С. 11-14.Crisby M., Nordin-Frcdriksson G., Shah P.K. et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization // Circulation. - 2001. - Vol. 103. - P. 926-933.Crisby M., Nordin-Frcdriksson G., Shah P.K. et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization // Circulation. - 2001. - Vol. 103. - P. 926-933.Goldstein J.A., Dcmetriou D., Grines C.L. et al. Multiple complex coronary plaques in patients with acute myocardial infarction // N. Engl. J. Med. - 2000. - Vol. 343. - P. 915-922.Goldstein J.A., Dcmetriou D., Grines C.L. et al. Multiple complex coronary plaques in patients with acute myocardial infarction // N. Engl. J. Med. - 2000. - Vol. 343. - P. 915-922.Curzen N., Patel D., Kemp M. et al. Can C-reactive protein or troponin T and I predict outcome in patients with acute myocardial infarction? // Congress of the European Society of Cardiology, 19-lh // Eur. Heart J. - 1997. - Vol. 18. - P. 1384.Curzen N., Patel D., Kemp M. et al. Can C-reactive protein or troponin T and I predict outcome in patients with acute myocardial infarction? // Congress of the European Society of Cardiology, 19-lh // Eur. Heart J. - 1997. - Vol. 18. - P. 1384.Muckel M., Maske J., Danne O. et al. Prospective validation of new protocol for the diagnosis of acute myocardial infarction using myoglobin, troponin I and CK-MB mass. Final results // Eur. Heart J.- 1997. Suppl. N. - P. 3672.Muckel M., Maske J., Danne O. et al. Prospective validation of new protocol for the diagnosis of acute myocardial infarction using myoglobin, troponin I and CK-MB mass. Final results // Eur. Heart J.- 1997. Suppl. N. - P. 3672.Pasceri V., Wilier J.T., Yeh E. Direct proinflammatory effect of C-reactive protein on human endothelial cells // Circulation. - 2000. - Vol. 102.- P. 2165-2168.Pasceri V., Wilier J.T., Yeh E. Direct proinflammatory effect of C-reactive protein on human endothelial cells // Circulation. - 2000. - Vol. 102.- P. 2165-2168.Pasceri V, Chang J., Willerson J.T. et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs // Circulation. 2001. - Vol. 103. - P. 2531-2534.Pasceri V, Chang J., Willerson J.T. et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs // Circulation. 2001. - Vol. 103. - P. 2531-2534.Zwaka T.P., Hombach V., Torzewski J. C-reactivc protein mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis // Circulation. - 2001. - Vol. 103. - P. 1194-1197.Zwaka T.P., Hombach V., Torzewski J. C-reactivc protein mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis // Circulation. - 2001. - Vol. 103. - P. 1194-1197.Пархоменко Л.Н., Лутай Я.М., Пономарева Г.В. и др. Диагностическое и прогностическое значение маркера системною воспаления С-реактивного протеина у больных с острыми коронарными синдромами // Укр. кардиол. журн. - 2002. - № 2. - С. 34Пархоменко Л.Н., Лутай Я.М., Пономарева Г.В. и др. Диагностическое и прогностическое значение маркера системною воспаления С-реактивного протеина у больных с острыми коронарными синдромами // Укр. кардиол. журн. - 2002. - № 2. - С. 34Biasucci L.M., Liuzzo G., Colizzi C. et al. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease // Ital. Heart J. - 2001. - Vol. 2, № 3. - P. 164-171.Biasucci L.M., Liuzzo G., Colizzi C. et al. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease // Ital. Heart J. - 2001. - Vol. 2, № 3. - P. 164-171.Capes S.E., Hunt D., Malbcrg K. et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview // Lancet. - 2000. - Vol. 355. - P. 773-778.Capes S.E., Hunt D., Malbcrg K. et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview // Lancet. - 2000. - Vol. 355. - P. 773-778.

The authors declare that there are no conflicts of interest present.